Search

Khatol S. Shahnan Shah

Examiner (ID: 11599, Phone: (571)272-0863 , Office: P/1645 )

Most Active Art Unit
1645
Art Unit(s)
1645
Total Applications
690
Issued Applications
341
Pending Applications
102
Abandoned Applications
265

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8406435 [patent_doc_number] => 20120238504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'Stable Formulations of Botulinum Toxin in Hydrogels' [patent_app_type] => utility [patent_app_number] => 13/440162 [patent_app_country] => US [patent_app_date] => 2012-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12058 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13440162 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/440162
Stable Formulations of Botulinum Toxin in Hydrogels Apr 4, 2012 Abandoned
Array ( [id] => 8767468 [patent_doc_number] => 20130095505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-18 [patent_title] => 'DETECTION OF LIPID OXIDISING ABZYMES IN SAMPLES' [patent_app_type] => utility [patent_app_number] => 13/439927 [patent_app_country] => US [patent_app_date] => 2012-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6565 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13439927 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/439927
DETECTION OF LIPID OXIDISING ABZYMES IN SAMPLES Apr 4, 2012 Abandoned
Array ( [id] => 9268767 [patent_doc_number] => 20140023684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-23 [patent_title] => 'Vaccine Against Pasteurellaceae' [patent_app_type] => utility [patent_app_number] => 14/008935 [patent_app_country] => US [patent_app_date] => 2012-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12253 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008935 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/008935
Vaccine Against Pasteurellaceae Mar 29, 2012 Abandoned
Array ( [id] => 10149033 [patent_doc_number] => 09181308 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-10 [patent_title] => 'Methods and compositions employing immunogenic fusion proteins' [patent_app_type] => utility [patent_app_number] => 14/007159 [patent_app_country] => US [patent_app_date] => 2012-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 24979 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14007159 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/007159
Methods and compositions employing immunogenic fusion proteins Mar 22, 2012 Issued
Array ( [id] => 9685347 [patent_doc_number] => 20140242111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-28 [patent_title] => 'Engineered Bacteria for Oral Delivery of Glucoregulatory Proteins' [patent_app_type] => utility [patent_app_number] => 14/003596 [patent_app_country] => US [patent_app_date] => 2012-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14392 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14003596 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/003596
Engineered bacteria for oral delivery of glucoregulatory proteins Mar 7, 2012 Issued
Array ( [id] => 9330503 [patent_doc_number] => 20140057285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-27 [patent_title] => 'COMPOSITIONS AND METHODS TARGETING FORCE GENERATION IN KINESIN' [patent_app_type] => utility [patent_app_number] => 14/003070 [patent_app_country] => US [patent_app_date] => 2012-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17143 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14003070 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/003070
COMPOSITIONS AND METHODS TARGETING FORCE GENERATION IN KINESIN Mar 4, 2012 Abandoned
Array ( [id] => 9204964 [patent_doc_number] => 20140004142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'PCSK9 VACCINE' [patent_app_type] => utility [patent_app_number] => 14/002505 [patent_app_country] => US [patent_app_date] => 2012-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 34058 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14002505 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/002505
PCSK9 VACCINE Feb 27, 2012 Abandoned
Array ( [id] => 8371099 [patent_doc_number] => 20120220490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'METHOD AND COMPOSITIONS FOR DETECTING BOTULINUM NEUROTOXIN' [patent_app_type] => utility [patent_app_number] => 13/403603 [patent_app_country] => US [patent_app_date] => 2012-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15552 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13403603 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/403603
Method and compositions for detecting botulinum neurotoxin Feb 22, 2012 Issued
Array ( [id] => 9756723 [patent_doc_number] => 20140287424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'SLIDE CHIP FOR DETECTION SENSOR OF FOOD-BORNE PATHOGENS AND PREPARATION METHOD THEREOF' [patent_app_type] => utility [patent_app_number] => 14/343213 [patent_app_country] => US [patent_app_date] => 2012-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2644 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343213 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/343213
Slide chip for detection sensor of food-borne pathogens and preparation method thereof Feb 21, 2012 Issued
Array ( [id] => 11388743 [patent_doc_number] => 09549974 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-24 [patent_title] => 'Method for selecting and producing vaccine components and vaccines based thereon' [patent_app_type] => utility [patent_app_number] => 13/397354 [patent_app_country] => US [patent_app_date] => 2012-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 19 [patent_no_of_words] => 17137 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13397354 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/397354
Method for selecting and producing vaccine components and vaccines based thereon Feb 14, 2012 Issued
Array ( [id] => 9190980 [patent_doc_number] => 20130330295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'ANTIGENIC GLY1 POLYPEPTIDE' [patent_app_type] => utility [patent_app_number] => 13/981404 [patent_app_country] => US [patent_app_date] => 2012-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7109 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13981404 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/981404
ANTIGENIC GLY1 POLYPEPTIDE Feb 6, 2012 Abandoned
Array ( [id] => 11343511 [patent_doc_number] => 09527905 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-27 [patent_title] => 'Antibodies that specifically bind Staphylococcus aureus alpha toxin and methods of use' [patent_app_type] => utility [patent_app_number] => 13/983804 [patent_app_country] => US [patent_app_date] => 2012-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 32 [patent_no_of_words] => 50661 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13983804 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/983804
Antibodies that specifically bind Staphylococcus aureus alpha toxin and methods of use Feb 6, 2012 Issued
Array ( [id] => 10587702 [patent_doc_number] => 09309305 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-12 [patent_title] => 'Anti-ricin antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/122366 [patent_app_country] => US [patent_app_date] => 2012-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 14547 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14122366 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/122366
Anti-ricin antibodies and uses thereof Jan 30, 2012 Issued
Array ( [id] => 12199889 [patent_doc_number] => 09902947 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-27 [patent_title] => 'CyaA-carried polypeptide(s) and use to induce both therapeutic and prophylactic immune responses' [patent_app_type] => utility [patent_app_number] => 13/981250 [patent_app_country] => US [patent_app_date] => 2012-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 20 [patent_no_of_words] => 17413 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13981250 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/981250
CyaA-carried polypeptide(s) and use to induce both therapeutic and prophylactic immune responses Jan 23, 2012 Issued
Array ( [id] => 9205002 [patent_doc_number] => 20140004178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'OMV VACCINE AGAINST BURKHOLDERIA INFECTIONS' [patent_app_type] => utility [patent_app_number] => 13/979037 [patent_app_country] => US [patent_app_date] => 2012-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 36548 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13979037 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/979037
OMV VACCINE AGAINST BURKHOLDERIA INFECTIONS Jan 11, 2012 Abandoned
Array ( [id] => 9197658 [patent_doc_number] => 20130336974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-19 [patent_title] => 'METHOD FOR DELIVERING AGENTS INTO CELLS USING BACTERIAL TOXINS' [patent_app_type] => utility [patent_app_number] => 13/978550 [patent_app_country] => US [patent_app_date] => 2012-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9364 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13978550 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/978550
Method for delivering agents into cells using bacterial toxins Jan 9, 2012 Issued
Array ( [id] => 9936889 [patent_doc_number] => 08986695 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-24 [patent_title] => 'Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB—SauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5' [patent_app_type] => utility [patent_app_number] => 13/298966 [patent_app_country] => US [patent_app_date] => 2011-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11238 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13298966 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/298966
Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB—SauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5 Nov 16, 2011 Issued
Array ( [id] => 10070696 [patent_doc_number] => 09109040 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-18 [patent_title] => 'Treatment and prevention of malaria' [patent_app_type] => utility [patent_app_number] => 13/884604 [patent_app_country] => US [patent_app_date] => 2011-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20732 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 201 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884604 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/884604
Treatment and prevention of malaria Nov 7, 2011 Issued
Array ( [id] => 10077362 [patent_doc_number] => 09115205 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-25 [patent_title] => 'Plasmodium falciparum circumsporozoite vaccine gene optimization for soluble protein expression' [patent_app_type] => utility [patent_app_number] => 13/880227 [patent_app_country] => US [patent_app_date] => 2011-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 20 [patent_no_of_words] => 13056 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13880227 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/880227
Plasmodium falciparum circumsporozoite vaccine gene optimization for soluble protein expression Oct 17, 2011 Issued
Array ( [id] => 11772486 [patent_doc_number] => 09381241 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-05 [patent_title] => 'Mucosal adjuvant composition' [patent_app_type] => utility [patent_app_number] => 13/876439 [patent_app_country] => US [patent_app_date] => 2011-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 7465 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13876439 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/876439
Mucosal adjuvant composition Sep 26, 2011 Issued
Menu